A molecular subtyping of ACC centered on TP63 expression has been proposed as opposed to constitutive activation of MYC induced by NOTCH mutation/pathway alteration, both indicated as drivers of unique regulatory programs in ACC, with direct prognostic implications9. This evidence concerns the gene TP63 and adrenal cortex carcinoma.